El Salvador Pacamara (Coffea arabica)

El Salvador Pacamara is a large-bean Arabica cultivar bred from Pacas and Maragogipe varieties, prized for its dense chlorogenic acid content, particularly 5-caffeoylquinic acid (5-CQA), which modulates glucose-6-phosphatase activity and NF-κB signaling. Its bioactive profile closely mirrors high-quality green Arabica extracts shown in clinical research to reduce inflammatory and glycemic markers.

Origin & History

El Salvador Pacamara is a rare hybrid cultivar variant of Coffea arabica, originating from El Salvador and derived from a cross between Pacas (a Bourbon mutation) and Maragogype (a Typica mutation). Prized in specialty coffee for its large beans and complex flavor profile, this cultivar contains polyphenols, caffeine, and chlorogenic acids similar to other C. arabica varieties.

Historical & Cultural Context

El Salvador Pacamara has no documented historical use in traditional medicine systems. This cultivar is primarily cultivated for specialty coffee beverage production, with recent experiments in leaf tea preparation, but not for medicinal applications.

Health Benefits

• May reduce inflammatory markers: Related C. arabica green coffee bean extract significantly reduced C-reactive protein levels (WMD: -0.017 mg/dL) in meta-analysis of 5 studies (moderate evidence)
• Potential glucose metabolism support: General chlorogenic acid studies from coffee report improvements in glucose tolerance and insulin sensitivity (preliminary evidence)
• Possible blood pressure benefits: Coffee-derived chlorogenic acids show blood pressure improvements via endothelial function enhancement in acute studies (preliminary evidence)
• Antioxidant properties: Contains catechins and chlorogenic acids, though specific concentrations for this cultivar are not quantified (preliminary evidence)
• Essential oil content: Pacamara coffee leaves contain up to 1.52 mL/100 g essential oils, higher than other varieties (preliminary evidence)

How It Works

The primary bioactive compounds in El Salvador Pacamara, chiefly 5-caffeoylquinic acid (5-CQA) and 3,4-dicaffeoylquinic acid, inhibit hepatic glucose-6-phosphatase, reducing postprandial glucose release into the bloodstream. Chlorogenic acids also suppress IκB kinase (IKK-β) activity, thereby attenuating NF-κB transcription and downstream production of pro-inflammatory cytokines including TNF-α and IL-6. Additionally, these polyphenols upregulate AMPK signaling in skeletal muscle, promoting GLUT4 translocation and improving peripheral insulin sensitivity.

Scientific Research

No human clinical trials specifically on El Salvador Pacamara were identified. Related evidence includes a meta-analysis of C. arabica green coffee bean extract showing significant CRP reduction, with greater effects at doses ≥1000 mg/day and in non-healthy subjects. General chlorogenic acid studies report metabolic benefits, but lack specific data for this cultivar.

Clinical Summary

A meta-analysis of 5 randomized controlled trials evaluating Coffea arabica green coffee bean extract found a statistically significant reduction in C-reactive protein levels (WMD: -0.017 mg/dL), supporting an anti-inflammatory effect with moderate-quality evidence. Separate human intervention studies using chlorogenic acid doses of 120–300 mg/day demonstrated reductions in fasting blood glucose of 5–10 mg/dL compared to placebo, though sample sizes were modest (n=20–60 per trial). Evidence specific to the Pacamara cultivar itself is not yet independently published, and extrapolations are drawn from its shared C. arabica phytochemical profile. Overall, evidence is promising but preliminary, requiring cultivar-specific trials for definitive conclusions.

Nutritional Profile

El Salvador Pacamara is a large-bean Coffea arabica cultivar (Pacas × Maragogipe cross) grown primarily at high elevations (1,200–1,800 m) in El Salvador. As a brewed coffee, a standard 240 mL cup provides approximately 2–5 kcal with negligible macronutrients (<0.3 g protein, <0.1 g fat, ~0 g carbohydrate, 0 g fiber). Key bioactive compounds per 240 mL brewed cup: • Caffeine: ~80–120 mg (typical arabica range; Pacamara beans tend toward moderate caffeine content, estimated 1.0–1.3% dry weight, slightly lower than some commercial arabica blends due to Maragogipe parentage which is associated with marginally reduced caffeine density). • Chlorogenic acids (CGAs): ~70–200 mg per cup depending on roast level; predominantly 5-O-caffeoylquinic acid (5-CQA), with smaller amounts of 3-CQA, 4-CQA, 3,4-diCQA, 3,5-diCQA, and 4,5-diCQA. Light-to-medium roasts typical of specialty Pacamara preparations preserve higher CGA content. Bioavailability of CGAs is approximately 33%, with extensive metabolism to caffeic acid, ferulic acid, and dihydrocaffeic acid by gut microbiota. • Trigonelline: ~40–80 mg per cup (degrades to nicotinic acid/niacin during roasting; medium roast yields ~1–2 mg niacin equivalent per cup). • Diterpenes (cafestol and kahweol): ~0.2–0.6 mg per cup in filtered coffee; substantially higher (6–12 mg) in unfiltered preparations. Arabica cultivars including Pacamara contain both cafestol and kahweol (robusta lacks significant kahweol). • Melanoidins (Maillard reaction products): ~500–700 mg per cup in medium roast; contribute antioxidant capacity and prebiotic-like activity. • Minerals per cup: Potassium ~116 mg (≈2.5% DV), Magnesium ~7 mg (≈1.7% DV), Manganese ~0.05 mg (≈2% DV), Phosphorus ~7 mg, Niacin (B3) ~0.5–2 mg (variable with roast from trigonelline conversion), Riboflavin (B2) ~0.2 mg (≈15% DV), Pantothenic acid (B5) ~0.6 mg (≈12% DV). Trace chromium (~0.5–1 µg). • Total polyphenol content: ~200–400 mg gallic acid equivalents per cup. • Antioxidant capacity (ORAC): approximately 2,500–3,000 µmol TE per 240 mL cup. • Specialty-relevant note: Pacamara's exceptionally large bean size (screen 18–20) and high-altitude Salvadoran terroir are associated with elevated sucrose content in green beans (~7.5–8.5% dry weight vs. ~6–7% for typical arabica), contributing to enhanced Maillard reaction products during roasting and potentially higher melanoidin yield. Higher sucrose also correlates with increased volatile aromatic precursors but does not contribute residual sugar to brewed coffee. • Lipid fraction in green bean: ~15–17% dry weight, predominantly linoleic acid (~44%), palmitic acid (~34%), oleic acid (~9%), and stearic acid (~7%); most retained in spent grounds during filtration. • Bioavailability notes: Caffeine is nearly 100% bioavailable with peak plasma at 30–60 min. CGA bioavailability is limited (~33% absorbed) but colonic metabolites (dihydrocaffeic acid, ferulic acid) extend biological activity over 8–12 hours. Mineral bioavailability from coffee is moderate; polyphenols may slightly inhibit non-heme iron absorption if consumed with iron-rich meals.

Preparation & Dosage

No clinically studied dosage ranges exist specifically for El Salvador Pacamara. Related green coffee bean extracts from C. arabica show effects at ≥1000 mg/day, though standardization was not specified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, chromium picolinate, cinnamon extract, alpha-lipoic acid

Safety & Interactions

El Salvador Pacamara coffee, like other Arabica-derived products, contains caffeine (typically 80–120 mg per 8 oz brewed cup), which may cause insomnia, tachycardia, or anxiety at doses exceeding 400 mg/day in healthy adults. Chlorogenic acids can modestly reduce blood pressure, creating an additive hypotensive interaction risk when combined with antihypertensive medications such as ACE inhibitors or calcium channel blockers. Green coffee extracts may interfere with warfarin metabolism via CYP1A2 inhibition, necessitating INR monitoring in anticoagulated patients. Consumption during pregnancy should be limited to under 200 mg caffeine daily per WHO guidelines, and individuals with irritable bowel syndrome may experience exacerbated symptoms due to chlorogenic acid-induced gastric acid secretion.